BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27377454)

  • 1. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
    Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
    J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
    Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
    Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
    Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
    J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses.
    Laffitte E; Skaria M; Jaunin F; Tamm K; Saurat JH; Favre B; Borradori L
    Br J Dermatol; 2001 Apr; 144(4):760-8. PubMed ID: 11298534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
    Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
    J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.
    Fairley JA; Fu CL; Giudice GJ
    J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.
    Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M
    J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.
    Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
    Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
    Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
    Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D
    J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
    Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
    Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.